Patents by Inventor Marcelo Gustavo Daelli

Marcelo Gustavo Daelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of erythropoietin glycoisoforms
    Patent number: 8343917
    Abstract: This invention relates to a combination of erythropoietin glycoisoforms, wherein such glycoisoforms may include a quantity of sialic acid ranging from 4 to 10 molecules of sialic acid per molecule of erythropoietin. The combination of glycoisoforms can be used for the treatment or prevention of sepsis, and used to prepare a pharmaceutical composition including such combination. The invention also encompasses a cell line producing a combination of erythropoietin glycoisoforms, procedures to obtain the cell line, a procedure to produce such a combination of glycoisoforms, and methods of treatment and prevention of sepsis.
    Type: Grant
    Filed: November 7, 2006
    Date of Patent: January 1, 2013
    Assignee: Protech Pharma, SA
    Inventors: Ricardo Agustin Lopez, Marcelo Gustavo Daelli, Dardo Alexis Pereira Bacci, Gabriel Ignacio Amadeo, Miriam Patricia Pereiro, Cristina Noemi Artana, Nestor Maskin, Bernardo Cesar Pistillo, Carolina Didier, Marina Etcheverrigaray, Ricardo Kratje
  • COMBINATION OF ERYTHROPOIETIN GLYCOISOFORMS
    Publication number: 20090220595
    Abstract: This invention relates to a combination of erythropoietin glycoisoforms, wherein such glycoisoforms may include a quantity of sialic acid ranging from 4 to 10 molecules of sialic acid per molecule of erythropoietin. The combination of glycoisoforms can be used for the treatment or prevention of sepsis, and used to prepare a pharmaceutical composition including such combination. The invention also encompasses a cell line producing a combination of erythropoietin glycoisoforms, procedures to obtain the cell line, a procedure to produce such a combination of glycoisoforms, and methods of treatment and prevention of sepsis.
    Type: Application
    Filed: November 7, 2006
    Publication date: September 3, 2009
    Inventors: Ricardo Agustin Lopez, Marcelo Gustavo Daelli, Dardo Alexis Pereira Bacci, Gabriel Ignacio Amadeo, Miriam Patricia Pereiro, Cristina Noemi Artana, Nestor Maskin, Bernardo Cesar Pistillo, Carolina Didier, Marina Etcheverrigaray, Ricardo Kratje
  • VERO CELL LINE WHICH IS ADAPTED TO GROW IN SUSPENSION
    Publication number: 20090203112
    Abstract: The invention relates to a Vero cell line that can be grown in serum-free and protein-free culture and in suspension culture in the absence of carrier for its adherence, and to production of viral vaccines using said cell line. More particularly, the present invention relates to establishment of a cell line that can be grown in suspension culture without need of the cells to be adhered to any supporting material. Furthermore, the present invention provides a process to obtain said Vero cell line and a process for producing viral vaccines with said cell line. The present invention further relates to the viruses obtained using the inventive method and to the vaccines formulated with said viruses.
    Type: Application
    Filed: October 3, 2006
    Publication date: August 13, 2009
    Applicants: ZELLTEK S.A.
    Inventors: Marcelo Gustavo Daelli, Ángela Guillermina Forno, Cristian Paillet, Marina Etcheverrigaray, Ricardo Kratje